These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6664891)
1. [Elements of etiopathogenesis of neoplasms. II. Role of genetic predisposition and immunologic mechanisms]. Steffen J Nowotwory; 1983; 33(3):185-201. PubMed ID: 6664891 [No Abstract] [Full Text] [Related]
2. The role of natural killer cells in human disease. Whiteside TL; Herberman RB Clin Immunol Immunopathol; 1989 Oct; 53(1):1-23. PubMed ID: 2670363 [No Abstract] [Full Text] [Related]
3. How efficient is immunological surveillance against cancer and why does it fail? Laroye GJ Lancet; 1974 Jun; 1(7866):1097-1100. PubMed ID: 4135256 [No Abstract] [Full Text] [Related]
4. [The relationship between immunological defence and the development of tumours]. Leone G Arch Sci Med (Torino); 1973; 130(4):273-82. PubMed ID: 17343168 [TBL] [Abstract][Full Text] [Related]
5. Immune surveillance and tumor defense mechanisms. von Kleist S Pathol Res Pract; 1980 Dec; 170(4):289-97. PubMed ID: 7012813 [No Abstract] [Full Text] [Related]
6. Organ transplantation and cancer. Fortner JG; Shiu MH Surg Clin North Am; 1974 Aug; 54(4):871-6. PubMed ID: 4610843 [No Abstract] [Full Text] [Related]
7. An introduction to tumour immunology. James K Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141 [TBL] [Abstract][Full Text] [Related]
8. The immune defense system. 3. Neoplasia. McNutt DR Rev Bras Pesqui Med Biol; 1974; 7(3):309-19. PubMed ID: 4278759 [No Abstract] [Full Text] [Related]
9. The cytolytic and regulatory role of natural killer cells in human neoplasia. Uchida A Biochim Biophys Acta; 1986 Dec; 865(3):329-40. PubMed ID: 2947630 [No Abstract] [Full Text] [Related]
10. c-myc, MHCI, and NK resistance in immunodeficiency lymphomas. Braun J; Felsher DW; Goodglick LA Ann N Y Acad Sci; 1992 May; 651():467-9. PubMed ID: 1599133 [No Abstract] [Full Text] [Related]
11. Host-susceptibility factors in cancer etiology. Fraser MC; Tucker MA Semin Oncol Nurs; 1986 Aug; 2(3):170-5. PubMed ID: 3638753 [No Abstract] [Full Text] [Related]
14. Immunodeficiency, immunosuppression, and susceptibility to neoplasms. Schwartz RS J Natl Cancer Inst Monogr; 2001; (28):5-9. PubMed ID: 11158200 [No Abstract] [Full Text] [Related]
15. Natural killer cells and cancer: a review. Burton RC Aust N Z J Surg; 1988 Oct; 58(10):761-5. PubMed ID: 3074763 [No Abstract] [Full Text] [Related]
16. Immunologic interreactions in neoplastic diseases. A brief review. Kushnick T Clin Pediatr (Phila); 1971 Jul; 10(7):372-6. PubMed ID: 4933466 [No Abstract] [Full Text] [Related]
17. [Effect of immune processes on the growth and regression of malignant tumors]. Russo V; Russo L Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500 [No Abstract] [Full Text] [Related]
18. Combined immunosuppressive activities of delta-9-tetrahydrocannabinol and murine retrovirus. Specter S; Lancz G; Westrich G; Friedman H Adv Exp Med Biol; 1991; 288():135-41. PubMed ID: 1659129 [No Abstract] [Full Text] [Related]
19. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VII. The effect of immunodeficiency disease. Pross HF; Gupta S; Good RA; Baines MG Cell Immunol; 1979 Mar; 43(1):160-75. PubMed ID: 313842 [No Abstract] [Full Text] [Related]
20. [Circulating serum interferon and its effect on human natural killer cell activity]. Cheknev SB; Ashmanova IaG; Pritsker AD; Latysheva OL Biull Eksp Biol Med; 1994 Dec; 118(12):619-22. PubMed ID: 7535580 [No Abstract] [Full Text] [Related] [Next] [New Search]